High-throughput screening (HTS) is an efficient means to rapidly identify promising compounds, but what happens when you get poor data? When using traditional HTS labels, you can run the risk of false positives and false negatives due to optical interference. Additionally, the difficulty of labeling novel compounds can further impede your hit identification process.
Join this webinar to discover how label-free SAMDI (Self-Assembled Monolayer Desorption Ionization) technology combines surface chemistry and mass spectrometry to avoid these pitfalls by:
- Minimizing false positive and negative results
- Optimizing assay development
- Analyzing biochemical activities and binding events for virtually any target
- Screening off-targets in parallel to ensure compound selectivity